BRAF and cancer: Such a difference in age of onset could partially be explained by the most common activating mutations in these two cancer types, SMO W535L (a C > A substitution)58 and BRAF V600E/K (A > T or AC > TT substitutions) involving UV lesions disparately impacted by loss of pol η.